3 Reasons to Buy Canopy Growth (TSX:WEED) Today

Canopy Growth Stock (TSX:WEED)(NYSE:CGC) just announced earnings. Here’s what you need to know, and the reasons why it’s still a buy.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) has almost done it. The company is on a roll lately, nearing all-time highs at the time of writing this article. But just looking at the last year alone, share have soared a 142%, and 2,343% in the last five years.

The increase has come from the promise of a bright future, a future supported by one thing: United States expansion. The company’s earnings support that outlook as well. Although the cannabis stock announced a loss of $829.3 million, these were one-time costs due to restructuring and impairments.

The company has proven time and again it can make the hard decisions to keep shareholders happy. But I’ll admit, shares are high right now. Even still, here are three reasons why I would still buy this company today.

Strong earnings

If you look beyond the loss, there is a lot going for Canopy Growth. The company saw record revenue of $152.5 million for its third quarter, an increase of 23% from the same time last year. Sales were up across the board for the company, however it’s still below where it should be thanks to the COVID-19 pandemic.

Earnings before interest, taxes, depreciation, and amortization (EBITDA) is a top metric for identifying operating performance, and this was still down by $68 million. However, this was an improvement from the $97 million loss in the same time last year. The company credits the increase in revenue growth and decrease in expenses for these results.

U.S. momentum

But what really has investors drooling is that the company strengthened its presence in the Canadian recreational market, and continue to expand in the United States. The U.S. market is going to be huge. The global cannabis market could be worth US$73.6 billion by 2027 according to analysts. If this is the case, Canopy Growth will be the driving force behind that growth.

The company continues to acquire and expand through the United States. Indeed, Chief Executive Officer David Klein believes that this year, we could even see federal legalization. This would drive cannabis sales through the roof. Though I’m not so sure about this, the Biden administration has stated it will decriminalize marijuana, a huge move that could lead to further states legalizing recreational use.

The biggest factor behind this momentum comes from the Acreage Holdings Inc. acquisition. The $3.4 billion acquisition would happen should legalization in the U.S. occur. That’s due to the company’s diverse cultivating, processing and dispensing throughout the U.S. Should legalization happen, Canopy will make a killing.

Profitability

But even without legalization management believes Canopy Growth will see profitability this year. This should happen by the second half of 2022, according to the earnings report. This would happen even with further research and development, acquisitions and consumer guidance.

Essentially, the future looks bright for this company. Although it may be up this year, you have to look at the cannabis market for what it is. Canopy Growth stands to be at the top of these cannabis stocks. It is the largest producer in the world as of writing, and likely to stay that way with these acquisitions underway. Cannabis is here to stay for investors, so look at this company not for the get-rich-quick scheme it once was, but the long-term hold that it is today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Canopy Growth.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »